Versor Investments’s NuVasive, Inc. NUVA Stock Holding History

Versor Investments’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-8,694	Closed	-$440K	–	309
2020 Q1	$440K	Sell	8,694 -5,106	-37%	-$342K	0.03%	124
2019 Q4	$1.07M	Buy	+13,800	New	+$974K	0.05%	145
2019 Q2	–	Sell	-14,460	Closed	-$821K	–	350
2019 Q1	$821K	Buy	14,460 +7,660	+113%	+$407K	0.08%	127
2018 Q4	$337K	Buy	+6,800	New	+$409K	0.08%	206

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Versor Investments's NUVA Position: Q2 2020 in Review

Versor Investments sold out of NuVasive, Inc. (NUVA) in Q2 2020, closing a stake of 8,694 shares — an estimated $440K sold.

Versor Investments first reported a position in NUVA in Q4 2018 and held it in 4 quarters. The position peaked at $1.07M in Q4 2019. 290 funds tracked by Wall St. Rank hold NUVA as of Q2 2020.

Versor Investments reported no remaining NuVasive, Inc. position as of Q2 2020 after selling out during the quarter.
Versor Investments sold 8,694 NuVasive, Inc. shares in Q2 2020, an estimated $440K.
Versor Investments first reported a position in NuVasive, Inc. in Q4 2018 and held it in 4 quarters.
Versor Investments's NuVasive, Inc. position peaked at $1.07M in Q4 2019.
290 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2020.

Based on Versor Investments's 13F filing for Q2 2020, filed 30 Jul 2020.